Neurological Institute Outcomes
Myasthenia gravis (MG) is a chronic disease affecting the junction between nerves and muscles, characterized by symptoms that may include fluctuating double vision, droopy eyelid, slurred speech, difficulty swallowing, and limb weakness. In some cases, weakness can be life-threatening, requiring inpatient care and sometimes intubation. Cures are uncommon, but many effective treatments are available. Cleveland Clinic’s Neuromuscular Center offers an individualized approach to treating patients with MG. The effectiveness of treatment depends on many factors, including the severity and duration of the disease, patient’s age and overall health, and treatment modality.
Myasthenia Gravis Patients: Change in Activities of Daily Living (N = 113)
2010 – 2020
MG-ADL = Myasthenia Gravis Activities of Daily Living